In C. elegans, two epigenetic enzymes, the H3K4me2 demethylase, SPR5, and the H3K9 methyltransferase, MET-2, are maternally deposited into the oocyte and cooperate to reestablish the epigenetic ground state by modifying histone methylation. Progeny of worms lacking
spr-5 and
met-2 accumulate high levels of H3K4me2 in the subsequent generation. This inappropriate H3K4me2 is associated with a low level of embryonic lethality, as well as a severe developmental delay and sterility in the small number of animals that reach adulthood. In addition, the progeny of
spr-5;
met-2 mutants improperly express germline genes in somatic tissues. We hypothesized that this improper expression could result in cell lineage defects. To interrogate how reprogramming defects may affect early embryonic development, we are taking advantage of the invariant C. elegans embryonic lineage by performing automated lineage tracing experiments in
spr-5;
met-2 progeny. Thus far, we observe several stages of defects. First, in early embryogenesis, the shape of the embryos is rounder, with a diameter that is greater than Wild Type, and the mutant cells divide faster than Wild Type. Since these defects are prior to the onset of zygotic transcription, they may be due directly to the decondensed state of chromatin associated with increased H3K4me2, or indirectly due to altered maternal RNAs and proteins. Second, after the onset of zygotic transcription, we observe many changes in cell timing, along with defects in cell migration. These defects may be due to the inappropriate somatic transcription of germline genes that we observe in the progeny of
spr-5;
met-2 mutants. Interestingly, those defects happened around the 100-cell stage or later. In C. elegans, the maternal to zygotic transition start during the early stages, but the higher peak of transition occurs around the 60 to the 100-cell stage. We hypothesized that the effect at this stage is due to the ectopic expression of germline genes, which is a consequence of the inappropriate inheritance of histone methylation. To address this question, we are currently performing single-cell RNA sequencing in the
spr-5;
met-2 mutants embryos at different cell stages including the 100-cell stage.